Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Human Genome Sciences
Human Genome Sciences
Value Investing, Biotech Style
Motley Fool
Sat, 01/29/11 - 11:35 am
investors
Benlysta
Human Genome Sciences
GSK
Cell Therapeutics
obesity. Orexigen Therapeutics
Vertex Pharmaceuticals
Exelixis
Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Human Genome Sciences, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit
Yahoo/MarketWire
Sat, 01/15/11 - 12:23 pm
Human Genome Sciences
lawsuits
Human Genome Sciences Tries to Put Toothpaste Back In the Tube
WSJ Online
Fri, 01/14/11 - 12:17 pm
Human Genome Sciences
GSK
Benlysta
lupus
9 Biotech Stocks for 2011
Seeking Alpha
Fri, 01/14/11 - 09:50 am
Cepheid
Cerus
Curis
Illumina
Questcor Pharmaceuticals
CompuGen
Spectrum Pharmaceuticals
Impax
Human Genome Sciences
Vertex Pharmaceuticals
Orexigen
Dendreon
Human Genome sets Lupus drug sales goal
Marketwatch
Tue, 01/11/11 - 12:27 pm
lupus
Human Genome Sciences
Benlysta
This NICE Deal Could Foreshadow 2011
Motley Fool
Fri, 12/31/10 - 10:55 am
NICE
GSK
Pfizer
Human Genome Sciences
Bristol-Myers Squibb
Merck
AstraZeneca
value-based pricing
2011 Drugmaker M&A Targets
Motley Fool
Fri, 12/31/10 - 10:00 am
M&A
Pfizer
Merck
Genzyme
Sanofi
JNJ
Crucell
ONYX Pharmaceuticals
Bayer
Momenta
Novartis
GSK
Human Genome Sciences
Vertex Pharmaceuticals
MannKind
Vivus
Savient
Three Upcoming Make-or-Break Biotech Approvals
Seeking Alpha
Sun, 12/19/10 - 11:22 am
Vertex Pharmaceuticals
Telaprevir
Merck
hepatitis C
cystic fibrosis
Human Genome Sciences
Benlysta
lupus
MannKind
Afrezza
inhaled insulin
Director Of Equity Research At RBC Capital Markets Covers Phase III Data For Multiple New Drugs; Find Out The Stocks That Investors Should Look At
Yahoo/Wall Street Transcript
Sat, 12/18/10 - 12:24 pm
Athenahealth
Abbott Laboratories
Beckman Coulter
Agilent
AstraZeneca
Provenge
Dendreon
Benlysta
Human Genome Sciences
Telaprevir
Vertex Pharmaceuticals
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
Human Genome Sciences and GlaxoSmithKline Announce FDA Extension of BENLYSTA® PDUFA Target Date to March 10, 2011
Yahoo/BusinessWire
Sat, 12/4/10 - 11:58 am
Human Genome Sciences
GSK
Benlysta
PDUFA
Biotech Calendar: Key Dates for December
TheStreet.com
Tue, 11/30/10 - 09:20 am
Delcath
Arena Pharmaceuticals
RXi Pharmaceuticals
Cell Therapeutics
Amgen
Incyte
Celgene
Corcept Therapeutics
Affymax
Targacept
Exelixis
Orexigen
ONYX Pharmaceuticals
Seattle Genetics
MannKind
Alimera
AstraZeneca
Human Genome Sciences
Lessons From A Losing Biotech Portfolio
TheStreet.com
Mon, 11/29/10 - 11:38 am
biotech
Keryx
Ariad Pharmaceuticals
Allos
Vertex Pharmaceuticals
Seattle Genetics
Human Genome Sciences
Spectrum Pharmaceuticals
Geron
StemCells
Exclusive Picks From Street’s Top Biotech Analyst
CNBC
Sat, 11/20/10 - 12:15 pm
Human Genome Sciences
Amgen
United Therapeutics
Human Genome downgraded over lupus drug potential
Marketwatch
Wed, 11/17/10 - 12:59 pm
lupus
Benlysta
Human Genome Sciences
Big Boost for Human Genome Sciences Stock Likely
Minyanville
Wed, 11/17/10 - 11:47 am
Benlysta
Human Genome Sciences
lupus
FDA
FDA Panel Backs Human Genome's Lupus Drug
TheStreet.com
Wed, 11/17/10 - 11:42 am
FDA
advisory panels
lupus
Benlysta
Human Genome Sciences
Human Genome: FDA Panel Live Blog
TheStreet.com
Tue, 11/16/10 - 11:56 am
Human Genome Sciences
FDA
advisory panels
Benlysta
Are These Biotechs Creating Value?
Motley Fool
Mon, 11/15/10 - 11:18 am
Seattle Genetics
Human Genome Sciences
Gilead Sciences
Celgene
biotech
Human Genome, StemCells lead drug stocks
Marketwatch
Mon, 11/15/10 - 10:53 am
drug stocks
StemCells
Human Genome Sciences
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
next ›
last »